Effects of brassinolide and chitosan on the growth and medicinal value of Astragalus membranaceus callus
摘要
Astragalus membranaceus (Fisch.) Bunge (A. membranaceus) is a pharmacologically important herb, yet its traditional cultivation and slow growth cycle limit supply. Callus induction represents an effective biotechnological approach to enhance bioactive compound production through in vitroculture. This study investigated chitosan (CHT: 50, 100, 150, 200 mg/L) and brassinolide (BL: 0.01, 0.05, 0.1, 0.15 mg/L) as elicitors for enhancing callus growth, antioxidant capacity, and secondary metabolite accumulation. All treatments significantly improved physiological traits, antioxidant parameters, and bioactive compound accumulation, with effects dependent on elicitor type and concentration. Treatment with 200 mg/L CHT maximized FW (+ 49.52%) and superoxide dismutase (SOD) activity (+ 108.33%), while suppressing malondialdehyde (MDA) content (-96.76%) and superoxide anion (O2·−) generation (-68.01%). It simultaneously induced the highest accumulation of alkaloids (6.39-fold), total flavonoids (2.99-fold), and total saponins (2.63-fold) compared to controls. Maximum polysaccharide content (+ 50.97%) was achieved at 50 mg/L CHT. The 0.1 mg/L BL treatment optimized dry weight (+ 88.10%), proline (+ 250%), glutathione (+ 151%), and SOD activity (+ 216.67%), while minimizing MDA (-95.52%) and O2·− (-61.63%) accumulation. This treatment also elevated flavonoid (3.55-fold), saponin (1.86-fold), and polysaccharide (+ 51.19%) content, and enhanced phenylalanine ammonia-lyase activity. These findings establish a foundation for scaling callus culture and optimizing pharmaceutical compound production, enabling concentration-specific optimization for industrial applications.